What they were paid
Aclaris Therapeutics Director Compensation Table · all 5 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $18,065 | $42,422 | $-1 | $120,486 |
| FY2024 | $70,875 | $4,937 | $11,505 | — | $87,317 |
| FY2023 | $61,500 | $92,339 | $40,542 | — | $194,381 |
| FY2022 | $60,000 | $65,261 | $152,293 | — | $277,554 |
| FY2021 | $58,126 | $73,496 | $171,755 | — | $303,377 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aclaris Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001104659-26-047262, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Aclaris Therapeutics, Inc. filed document, accession 0001104659-26-047262. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.
Get the Aclaris Therapeutics Board Governance Report
$120,486 Anand Mehra, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Aclaris Therapeutics pays directors a $40,000 cash retainer and $320,000 in Stock Options and RSUs.
Committees
FY2025 · as the proxy prints themCompensation (Chair)
The rest of the Aclaris Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Schiff | Independent Director | $100,486 |
| Christopher Molineaux | Independent Director | $141,986 |
| Hugh Davis | Director | — |
| Maxine Gowen | Independent Director | $107,986 |
| Neal Walker | Chair of the Board | — |
| Vincent Milano | Independent Director | $120,486 |
| William Humphries | Independent Director | $112,486 |
The full Aclaris Therapeutics compensation record
free company briefThis page is one director within Aclaris Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Aclaris Therapeutics proxy · each links to its own free briefOrder ACRS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.